Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Vitamin D Supplementation and Cardiovascular Disease Risk

Vitamin D Supplementation and Cardiovascular Disease Risk Letters 1. Brush JE Jr. Shared goals and clear roles for cardiovascular team-based care. Despite advances in interventional cardiology and de- JAMA Cardiol. 2017;2(6):591-592. vices, drug therapy remains a core strategy to reduce cardio- 2. Vaduganathan M, Patel NK, Bergmark BA. Collaborative care in an evolving vascular-related morbidity and mortality. Yet these poten- health care delivery landscape: cardiology fellows in training and advanced tially life-saving medications are underused, as medication practice professionals. JAMA Cardiol. 2017;2(6):587-588. adherence and adherence to evidence-based guidelines re- 3. Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of 3,4 mains suboptimal. Patients with cardiovascular disease are Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017;2(4):361-369. often older and receiving high-risk cardiovascular medica- tions (eg, anticoagulants), and therefore, these patients are 4. Ferdinand KC, Senatore FF, Clayton-Jeter H, et al. Improving medication adherence in cardiometabolic disease: practical and regulatory implications. more susceptible to adverse drug events and polypharmacy. J Am Coll Cardiol. 2017;69(4):437-451. Pharmacists are unique in that they are the only member of 5. Dunn SP, Birtcher KK, Beavers CJ, et al. The role of the clinical pharmacist in the health care team with focused http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Vitamin D Supplementation and Cardiovascular Disease Risk

Zittermann, Armin; Pilz, Stefan
JAMA Cardiology , Volume 2 (11) – Nov 30, 2017
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/vitamin-d-supplementation-and-cardiovascular-disease-risk-hnEpv0kDAP

References (5)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2017.2935
Publisher site
See Article on Publisher Site

Abstract

Letters 1. Brush JE Jr. Shared goals and clear roles for cardiovascular team-based care. Despite advances in interventional cardiology and de- JAMA Cardiol. 2017;2(6):591-592. vices, drug therapy remains a core strategy to reduce cardio- 2. Vaduganathan M, Patel NK, Bergmark BA. Collaborative care in an evolving vascular-related morbidity and mortality. Yet these poten- health care delivery landscape: cardiology fellows in training and advanced tially life-saving medications are underused, as medication practice professionals. JAMA Cardiol. 2017;2(6):587-588. adherence and adherence to evidence-based guidelines re- 3. Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of 3,4 mains suboptimal. Patients with cardiovascular disease are Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017;2(4):361-369. often older and receiving high-risk cardiovascular medica- tions (eg, anticoagulants), and therefore, these patients are 4. Ferdinand KC, Senatore FF, Clayton-Jeter H, et al. Improving medication adherence in cardiometabolic disease: practical and regulatory implications. more susceptible to adverse drug events and polypharmacy. J Am Coll Cardiol. 2017;69(4):437-451. Pharmacists are unique in that they are the only member of 5. Dunn SP, Birtcher KK, Beavers CJ, et al. The role of the clinical pharmacist in the health care team with focused

Journal

JAMA Cardiology – American Medical Association

Published: Nov 30, 2017

There are no references for this article.